国产精品国产三级区别第一集,亚洲精品国产成人,精品人妻无码一区二区三区,人妻熟妇乱又伦精品视频

咨詢熱線

15000266580

當(dāng)前位置:首頁  >  技術(shù)文章  >  日本批準(zhǔn)利用干細(xì)胞療法治療眼部疾病

日本批準(zhǔn)利用干細(xì)胞療法治療眼部疾病

更新時間:2013-07-26      點(diǎn)擊次數(shù):3318

   日本研究人員獲得批準(zhǔn),可以開展利用干細(xì)胞療法治療老年性黃斑變性(age-related macular degeneration,AMD),一種引起老年人視力下降的主要疾病。日本的研究人員誘導(dǎo)AMD患者身上取下的皮膚細(xì)胞使其處于一種類似于干細(xì)胞的狀態(tài)后再將其轉(zhuǎn)至患者,以達(dá)到治療效果。

干細(xì)胞具有廣泛的性,具有廣泛的醫(yī)療前景。去年,Kyoto University的Shinya Yamanaka即憑借干細(xì)胞領(lǐng)域的研究獲得諾貝爾獎。

詳細(xì)英文報(bào)道:

Japanese researchers have won permission to embark on a pioneering clinical study of a stem cell therapy for age-related macular degeneration, a major cause of vision loss in aging patients. The planned trial is being hailed as the first human test of a stem cell therapy made from patients' own cells.

Japan provides an appropriate proving ground for induced pluripotent stem (iPS) cell therapies. Last year professor Shinya Yamanaka of Kyoto University won a piece of a Nobel Prize for his work on converting adult cells into stem cells. The stem cells have broad potential in medicine because they can evolve into a variety to cell types with the potential to repair diseased or damaged organs, and they skirt the political quagmire of harvesting stem cells from human embryos.

As AFP reported, researchers in the Japanese study plan to take skin cells from AMD patients, coax the cells into a stem-like state, and then reintroduce them to the patients. The study calls for testing the therapeutic approach in 6 patients, with the trial set to begin next year in Kobe. Applications to conduct the trial came from the Riken Center for Developmental Biology and the Institute of Biomedical Research and Innovation.

Stem cells offer a whole new way to treat vision problems. Today, AMD patients take injected therapies such as Eylea and Lucentis to combat the disease by inhibiting VEGF to stymie the formation of leaky blood vessels, which lead to deterioration of the eye tissue that is key to central vision.

However, with pioneering clinical trials comes great risk. As professor Chris Mason of University College London noted to the BBC, researchers lack evidence on the safety of iPS cells in humans. The hope is that using patients' own cells to generate the therapies could reduce the risk of their bodies rejecting the stem cells.

 

聯(lián)系方式

郵箱:xiangfbio@163.com

地址:上海市虹口區(qū)四平路710號7層

咨詢熱線

400-821-8510

(周一至周日9:00- 19:00)

在線咨詢
  • 掃一掃 微信咨詢

Copyright©2025 上海復(fù)祥生物科技有限公司 All Right Reserved    備案號:滬ICP備10013034號-2     sitemap.xml
技術(shù)支持:化工儀器網(wǎng)    管理登陸
久久精品麻豆日日躁夜夜躁妓女| 久草视频新免费| 久久久久亚洲AV成人片乱码| 一女三男做2爱a片免费| 国产精品视频人人做人人爽| 女人被狂躁到高潮视频免费网站| 久久精品国产亚洲av不卡| 精品毛片乱码1区2区3区| 出轨熟女人妻hd中文| 秋霞影视欧美高清av片| 亚洲熟妇成人精品一区| 日本妇人成熟a片免费现看| 又大又粗欧美黑人aaaaa片| 欧美军警GAY巨大粗长| 国产AV人人夜夜澡人人爽| 精品人妻无码一区二区三区性| videosgrstv欧美| 无码精品视频一区二区三区| 亚洲乱亚洲乱妇24p| 日本久久高清一区二区三区毛片| 三上悠亚人妻中文字幕在线| 久久亚洲AV无码国产精品| 国产性色强伦免费视频| 亚洲精品无码成人| 亚洲午夜精品A片久久WWW解说| 亚洲AV无码国产精品色软件| 入禽太深免费完整版电影| 精品无码三级在线观看视频| 日韩AV高清无码| 欧美黑人乱大交BD| 日韩人妻一区二区三区免费| 隔壁人妻偷人bd中字| 国产精品色情国产三级在| 中文字幕欧美人妻精品一区| 免费精品一区二区三区第35二区| 久久久久国产一区二区三区| MM1313亚洲精品无码久久| 欧美黑人粗暴多交高潮水最多| 欧美老熟妇乱人伦人妻| 免费无码av一区二区三区| 国产成人午夜精品一区二区三区 |